Helius Medical Technologies Inc (HSDT)
1.51
-0.01
(-0.66%)
USD |
NASDAQ |
May 17, 16:00
1.51
0.00 (0.00%)
After-Hours: 20:00
Helius Medical Technologies Cash from Operations (Quarterly): -3.001M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -3.001M |
December 31, 2023 | -2.034M |
September 30, 2023 | -2.452M |
June 30, 2023 | -2.74M |
March 31, 2023 | -3.19M |
December 31, 2022 | -2.143M |
September 30, 2022 | -3.821M |
June 30, 2022 | -3.664M |
March 31, 2022 | -4.682M |
December 31, 2021 | -3.463M |
September 30, 2021 | -3.235M |
June 30, 2021 | -3.769M |
March 31, 2021 | -2.921M |
December 31, 2020 | -2.171M |
September 30, 2020 | -2.588M |
June 30, 2020 | -3.228M |
March 31, 2020 | -3.751M |
December 31, 2019 | -4.539M |
September 30, 2019 | -5.246M |
June 30, 2019 | -4.414M |
March 31, 2019 | -6.80M |
December 31, 2018 | -5.145M |
Date | Value |
---|---|
September 30, 2018 | -3.348M |
June 30, 2018 | -6.268M |
March 31, 2018 | -4.86M |
December 31, 2017 | -5.086M |
September 30, 2017 | -4.943M |
June 30, 2017 | -6.432M |
March 31, 2017 | -2.864M |
September 30, 2016 | -1.724M |
June 30, 2016 | -2.369M |
March 31, 2016 | -1.683M |
December 31, 2015 | -2.861M |
September 30, 2015 | -1.248M |
June 30, 2015 | -2.146M |
March 31, 2015 | -1.941M |
December 31, 2014 | -1.621M |
September 30, 2014 | -2.218M |
June 30, 2014 | -0.5409M |
March 31, 2014 | -0.3217M |
December 31, 2013 | -0.0099M |
September 30, 2013 | -0.017M |
June 30, 2013 | 0.00 |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-5.246M
Minimum
Sep 2019
-2.034M
Maximum
Dec 2023
-3.353M
Average
-3.232M
Median
Cash from Operations (Quarterly) Benchmarks
ARCA biopharma Inc | -1.528M |
Integra Lifesciences Holdings Corp | 15.76M |
NeuroOne Medical Technologies Corp | -3.809M |
Perspective Therapeutics Inc | 13.85M |
Electromed Inc | 1.351M |
Cash from Operations (Quarterly) Related Metrics
Cash from Investing (Quarterly) | -0.005M |
Cash from Financing (Quarterly) | 1.463M |
Free Cash Flow | -10.24M |
Free Cash Flow Per Share (Quarterly) | -3.678 |
Free Cash Flow to Equity (Quarterly) | -3.006M |
Free Cash Flow to Firm (Quarterly) | -2.998M |
Free Cash Flow Yield | -1.00K% |